Advertisement

Bayer Wins Early US Approval for Colon Cancer Drug

Published on: 

The U.S. Food and Drug Administration on Thursday approved a new drug for advanced colon cancer developed by Bayer AG, a month ahead of the agency's expected action date for a decision.

The drug, to be sold under the brand name Stivarga, was approved to treat colon cancer that has progressed after prior treatment or that has spread to other parts of the body, the agency said.

Advertisement

Read the full story: reut.rs/QyWLff

Source: Reuters


Advertisement
Advertisement